198 related articles for article (PubMed ID: 11114638)
21. [Von Hippel-Lindau disease].
Shuin T; Ashida S; Yao M; Kanno H
Nihon Rinsho; 2000 Jul; 58(7):1448-54. PubMed ID: 10921322
[TBL] [Abstract][Full Text] [Related]
22. Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center.
Park TY; Lee SK; Park JS; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
Scand J Gastroenterol; 2015 Mar; 50(3):360-7. PubMed ID: 25562111
[TBL] [Abstract][Full Text] [Related]
23. Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors.
Vortmeyer AO; Huang SC; Koch CA; Governale L; Dickerman RD; McKeever PE; Oldfield EH; Zhuang Z
Cancer Res; 2000 Nov; 60(21):5963-5. PubMed ID: 11085513
[TBL] [Abstract][Full Text] [Related]
24. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
Zbar B
Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
[TBL] [Abstract][Full Text] [Related]
25. Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome.
Penitenti F; Landoni L; Scardoni M; Piredda ML; Cingarlini S; Scarpa A; D'Onofrio M; Girelli D; Davi MV
Endocrine; 2021 Oct; 74(1):180-187. PubMed ID: 34036514
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations.
Libutti SK; Choyke PL; Bartlett DL; Vargas H; Walther M; Lubensky I; Glenn G; Linehan WM; Alexander HR
Surgery; 1998 Dec; 124(6):1153-9. PubMed ID: 9854597
[TBL] [Abstract][Full Text] [Related]
27. Hemangioblastomas of the retina: impact of von Hippel-Lindau disease.
Niemelä M; Lemeta S; Sainio M; Rauma S; Pukkala E; Kere J; Böhling T; Laatikainen L; Jääskeläinen J; Summanen P
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1909-15. PubMed ID: 10845616
[TBL] [Abstract][Full Text] [Related]
28. Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study.
Else T; Jonasch E; Iliopoulos O; Beckermann KE; Narayan V; Maughan BL; Oudard S; Maranchie JK; Iversen AB; Goldberg CM; Fu W; Perini RF; Liu Y; Linehan WM; Srinivasan R
Clin Cancer Res; 2024 May; 30(9):1750-1757. PubMed ID: 38393723
[TBL] [Abstract][Full Text] [Related]
29. Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome.
Weisbrod AB; Kitano M; Thomas F; Williams D; Gulati N; Gesuwan K; Liu Y; Venzon D; Turkbey I; Choyke P; Yao J; Libutti SK; Nilubol N; Linehan WM; Kebebew E
J Am Coll Surg; 2014 Feb; 218(2):163-9. PubMed ID: 24440063
[TBL] [Abstract][Full Text] [Related]
30. [Prevention of renal carcinoma: the nutri-genetic approach].
Junien C; Dupret JM; Gallou C; Longuemaux S; Richard S; Saquet C; Krishnamoorty R; Delomenie C; Droz D; Bouvier R; Chauveau D; Joly D; Grunfeld JP; Chretien Y; Mejean A; Beroud C
J Soc Biol; 2000; 194(1):29-38. PubMed ID: 11107547
[TBL] [Abstract][Full Text] [Related]
31. Triple pancreatic lesion in a patient with Von Hippel-Lindau disease.
López Marcano AJ; Ramia Ángel JM; de la Plaza Llamas R; Al-Swely F; Manuel Vázquez A; García Amador C; Candia A
Gastroenterol Hepatol; 2018; 41(7):446-448. PubMed ID: 28882614
[No Abstract] [Full Text] [Related]
32. [VHL, angiogenesis and renal carcinoma: the puzzle is complete].
Richard S
Ann Pathol; 2000 Mar; 20(2):107-9. PubMed ID: 10740003
[No Abstract] [Full Text] [Related]
33. Metastatic pancreatic neuroendocrine tumor to the central nervous system in a patient with von Hippel-Lindau disease: A case report and literature review.
Reynolds MR; Crilly SM; Sweeney KJ; Farrell M; Rawluk D
Br J Neurosurg; 2015 Apr; 29(2):291-3. PubMed ID: 25232806
[TBL] [Abstract][Full Text] [Related]
34. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
[TBL] [Abstract][Full Text] [Related]
35. von Hippel-Lindau disease.
Couch V; Lindor NM; Karnes PS; Michels VV
Mayo Clin Proc; 2000 Mar; 75(3):265-72. PubMed ID: 10725953
[TBL] [Abstract][Full Text] [Related]
36. [Pancreatic neuroendocrine tumors and von Hippel-Lindau disease].
Musso C; Paraf F; Petit B; Archambeaud-Mouveroux F; Valleix D; Labrousse F
Ann Pathol; 2000 Mar; 20(2):130-3. PubMed ID: 10740008
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic neuroendocrine tumours in patients with von Hippel-Lindau disease.
Zwolak A; Świrska J; Tywanek E; Dudzińska M; Tarach JS; Matyjaszek-Matuszek B
Endokrynol Pol; 2020; 71(3):256-259. PubMed ID: 32797472
[TBL] [Abstract][Full Text] [Related]
38. Neuroendocrine tumor of the pancreas and bilateral adrenal pheochromocytomas. A rare manifestation of von Hippel-Lindau disease in childhood.
Langrehr JM; Bahra M; Kristiansen G; Neumann HP; Neumann LM; Plöckinger U; Lopez-Hänninen E
J Pediatr Surg; 2007 Jul; 42(7):1291-4. PubMed ID: 17618900
[TBL] [Abstract][Full Text] [Related]
39. The von Hippel-Lindau tumor suppressor gene.
Kondo K; Kaelin WG
Exp Cell Res; 2001 Mar; 264(1):117-25. PubMed ID: 11237528
[TBL] [Abstract][Full Text] [Related]
40. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.
Siemeister G; Weindel K; Mohrs K; Barleon B; Martiny-Baron G; Marmé D
Cancer Res; 1996 May; 56(10):2299-301. PubMed ID: 8625303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
